Prigrel may be reimbursable depending on ruling of Plavix's patent suit

The government plans to get Chong Kun Dang's Prigrel (clopidogrel resignate) reimbursed depending on the ruling of Patent Court over Plavix's patent suit, according to an official at the Ministry of Health and Welfare on October 12.

The National Health Insurance Corporation said on October 2 that it would not list Prigrel into the positive list as the drug's superior efficacy over price can...